BRPI0906352A2 - Derivado de tiazol e uso do mesmo como inibidores de vap-1 - Google Patents
Derivado de tiazol e uso do mesmo como inibidores de vap-1Info
- Publication number
- BRPI0906352A2 BRPI0906352A2 BRPI0906352-8A BRPI0906352A BRPI0906352A2 BR PI0906352 A2 BRPI0906352 A2 BR PI0906352A2 BR PI0906352 A BRPI0906352 A BR PI0906352A BR PI0906352 A2 BRPI0906352 A2 BR PI0906352A2
- Authority
- BR
- Brazil
- Prior art keywords
- thiazole
- inhibitors
- derivative
- thiazole derivative
- thiazole inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008021588 | 2008-01-31 | ||
PCT/JP2009/052015 WO2009096609A1 (en) | 2008-01-31 | 2009-01-30 | Thiazole derivative and use thereof as vap-1 inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0906352A2 true BRPI0906352A2 (pt) | 2015-07-07 |
Family
ID=40546096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0906352-8A BRPI0906352A2 (pt) | 2008-01-31 | 2009-01-30 | Derivado de tiazol e uso do mesmo como inibidores de vap-1 |
Country Status (18)
Country | Link |
---|---|
US (1) | US8507690B2 (pt) |
EP (4) | EP2252604B1 (pt) |
JP (1) | JP5415430B2 (pt) |
KR (1) | KR101622414B1 (pt) |
CN (1) | CN101932568B (pt) |
AR (1) | AR070336A1 (pt) |
AU (1) | AU2009209885B2 (pt) |
BR (1) | BRPI0906352A2 (pt) |
CA (1) | CA2712962C (pt) |
DK (1) | DK2639229T3 (pt) |
ES (2) | ES2527014T3 (pt) |
HK (2) | HK1152293A1 (pt) |
MX (1) | MX2010008460A (pt) |
NZ (1) | NZ587205A (pt) |
PT (1) | PT2639229E (pt) |
RU (1) | RU2496776C9 (pt) |
TW (1) | TWI437986B (pt) |
WO (1) | WO2009096609A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI490214B (zh) * | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為vap-1抑制劑之用途 |
UA112154C2 (uk) * | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
JP5947724B2 (ja) * | 2009-12-21 | 2016-07-06 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | シクロフィリンの新しいインヒビター及びその使用 |
TWI594764B (zh) * | 2010-04-12 | 2017-08-11 | 生化治療公司 | 治療用途 |
HUE028394T2 (en) | 2011-03-15 | 2016-12-28 | Astellas Pharma Inc | Guanidin Compound |
US20160113893A1 (en) | 2013-06-12 | 2016-04-28 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
WO2015189534A1 (en) | 2014-06-12 | 2015-12-17 | Proximagen Limited | Vap-1 inhibitors for treating muscular dystrophy |
JP2018080113A (ja) | 2015-05-27 | 2018-05-24 | 株式会社アールテック・ウエノ | 脳梗塞処置剤 |
JP2018076236A (ja) | 2015-06-05 | 2018-05-17 | 株式会社アールテック・ウエノ | がんを処置するための医薬組成物 |
FR3037954B1 (fr) * | 2015-06-24 | 2017-08-11 | Michelin & Cie | Procede de synthese de molecules azo-dicarbonylees porteuses de groupes associatifs |
CA3007768A1 (en) | 2015-12-07 | 2017-06-15 | Benevolentai Cambridge Limited | Vap-1 inhibitors for treating pain |
MX2019005867A (es) * | 2016-11-28 | 2019-08-14 | Teijin Pharma Ltd | Farmaco terapeutico o farmaco profilactico para nefropatia diabetica. |
US11524048B2 (en) | 2019-05-09 | 2022-12-13 | The Feinstein Institutes For Medical Research | HMGB1 antagonist treatment of severe sepsis |
CN113924290A (zh) * | 2019-05-09 | 2022-01-11 | 范因斯坦医学研究院 | 硫代半肼基甲酸酯及其用途 |
US11883461B2 (en) | 2019-05-09 | 2024-01-30 | The Feinstein Institutes For Medical Research | HMGB1 antagonist treatment of severe sepsis |
SE544131C2 (en) * | 2020-03-16 | 2022-01-04 | Pvac Medical Tech Ltd | Use of substance and pharmaceutical composition thereof, and medical treatments or uses thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1181871B (it) | 1985-04-01 | 1987-09-30 | Consiglio Nazionale Ricerche | Inibitori selettivi delle benzilamminossidasi rispetto ad altre amminossidasi |
TW205041B (pt) * | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co | |
AU4055593A (en) | 1992-05-15 | 1993-12-13 | University Of Saskatchewan | Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis |
US6114365A (en) * | 1999-08-12 | 2000-09-05 | Pharmacia & Upjohn S.P.A. | Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
PL360374A1 (en) | 2000-07-05 | 2004-09-06 | Biotie Therapies Corporation | Inhibitors of copper-containing amine oxidases |
ES2168084B1 (es) | 2000-11-07 | 2003-11-16 | Univ Barcelona | Combinacion de aminas y compuestos de vanadio (iv) (v) para el tratatamiento y/o la prevencion de la diabetes mellitus. |
WO2002038153A1 (en) | 2000-11-09 | 2002-05-16 | Biovitrum Ab | New use of 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine derivatives |
CN100491361C (zh) * | 2003-01-27 | 2009-05-27 | 安斯泰来制药有限公司 | 噻唑衍生物及其作为vap-1抑制剂的用途 |
WO2004067521A1 (en) * | 2003-01-27 | 2004-08-12 | Astellas Pharma Inc. | Thiazole derivatives and their use as vap-1 inhibitors |
WO2004087138A1 (en) * | 2003-03-31 | 2004-10-14 | Sucampo Ag | Method for treating vascular hyperpermeable disease |
US20070208068A1 (en) * | 2004-03-18 | 2007-09-06 | R-Tech Ueno, Ltd. & Astellas Pharma Inc. | Aqueous Composition Comprising Thiazole Derivative |
DE602005013793D1 (de) | 2004-07-27 | 2009-05-20 | Astellas Pharma Inc | Thiazolderivate mit vap-1-hemmender wirkung |
EP1791835A2 (en) | 2004-09-09 | 2007-06-06 | Astellas Pharma Inc. | Thiazole derivatives having vap-1 inhibitory activity |
TW200835687A (en) | 2006-11-30 | 2008-09-01 | R Tech Ueno Ltd | Thiazole derivatives and their use as VAP-1 inhibitor |
KR20100034024A (ko) * | 2007-06-25 | 2010-03-31 | 가부시키가이샤 아루떼꾸 우에노 | 저산소 또는 허혈에 따른 안질환용 조성물 |
EP2213303A4 (en) | 2007-10-19 | 2011-12-28 | R Tech Ueno Ltd | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT |
-
2009
- 2009-01-23 TW TW098102784A patent/TWI437986B/zh not_active IP Right Cessation
- 2009-01-30 US US12/864,773 patent/US8507690B2/en not_active Expired - Fee Related
- 2009-01-30 RU RU2010136301/04A patent/RU2496776C9/ru not_active IP Right Cessation
- 2009-01-30 AR ARP090100311A patent/AR070336A1/es unknown
- 2009-01-30 NZ NZ587205A patent/NZ587205A/en not_active IP Right Cessation
- 2009-01-30 JP JP2010529187A patent/JP5415430B2/ja not_active Expired - Fee Related
- 2009-01-30 PT PT131721268T patent/PT2639229E/pt unknown
- 2009-01-30 CN CN200980103755.1A patent/CN101932568B/zh not_active Expired - Fee Related
- 2009-01-30 AU AU2009209885A patent/AU2009209885B2/en not_active Ceased
- 2009-01-30 EP EP09705640.2A patent/EP2252604B1/en not_active Not-in-force
- 2009-01-30 EP EP13172126.8A patent/EP2639229B9/en not_active Not-in-force
- 2009-01-30 BR BRPI0906352-8A patent/BRPI0906352A2/pt active Search and Examination
- 2009-01-30 WO PCT/JP2009/052015 patent/WO2009096609A1/en active Application Filing
- 2009-01-30 KR KR1020107017937A patent/KR101622414B1/ko not_active IP Right Cessation
- 2009-01-30 EP EP13185390.5A patent/EP2676955B1/en not_active Not-in-force
- 2009-01-30 ES ES13172126.8T patent/ES2527014T3/es active Active
- 2009-01-30 MX MX2010008460A patent/MX2010008460A/es active IP Right Grant
- 2009-01-30 EP EP13172130.0A patent/EP2650287B9/en not_active Not-in-force
- 2009-01-30 CA CA2712962A patent/CA2712962C/en not_active Expired - Fee Related
- 2009-01-30 DK DK13172126.8T patent/DK2639229T3/da active
- 2009-01-30 ES ES09705640.2T patent/ES2452834T3/es active Active
-
2011
- 2011-06-20 HK HK11106277.8A patent/HK1152293A1/xx not_active IP Right Cessation
-
2013
- 2013-11-14 HK HK13112767.1A patent/HK1185348A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0906352A2 (pt) | Derivado de tiazol e uso do mesmo como inibidores de vap-1 | |
BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
BRPI0913322A2 (pt) | derivado de benzeno ou tiofeno e uso do mesmo como inibidor de vap-1 | |
CR20130360A (es) | Compuesto heterocíclico y su uso | |
BRPI1012333A2 (pt) | atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso | |
BR112012018329A2 (pt) | agentes de coloração e métodos de uso destes | |
BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
DOP2010000260A (es) | Derivado heterociclico fusionado y su uso | |
BRPI0906186A2 (pt) | composto e uso de um composto | |
BRPI1007494A2 (pt) | composto e uso do mesmo | |
BRPI0915717A2 (pt) | ferramenta de avaliação de cascalho e métodos de uso | |
BR112012002349A2 (pt) | composto,e, uso do mesmo | |
FI20085839A0 (fi) | Menetelmiä ja välineitä pehmytkudosteknologiaan | |
BRPI0911444A2 (pt) | benzoimidazóis como inibidores de prolil hidroxilase | |
BRPI0913086A2 (pt) | Composições antimicrobianas e métodos de uso | |
BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
BRPI0920263A2 (pt) | composto, uso do composto, composição, e, método | |
BRPI0914536A2 (pt) | tiadiazoliloxifenilamidinas e o uso destas como fungicidas | |
BRPI0907931A2 (pt) | Derivado de pirrolopirimidina como inibidor de pi3k e uso do mesmo | |
BRPI1014544A2 (pt) | anticorpors anti-il-17f e metodos de uso dos mesmos | |
BRPI0916769A2 (pt) | derivados de benzilbenzeno deuterados e métodos de uso | |
BR112013010988A2 (pt) | composição fluída e uso | |
BRPI0910987A2 (pt) | derivados de triazolopiridinona para uso como inibidores de estearoil-coa dessaturase | |
BRPI0922344A2 (pt) | inibidores de tfpi e métodos de uso | |
BRPI1005670A2 (pt) | composições adjuvantes e métodos de uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2499 DE 27-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |